MOESM4 of Effect of mushroom Agaricus blazei on immune response and development of experimental cerebral malaria

Additional file 4. There were no differences in parasitaemia and mortality between those mice treated with fraction A and untreated mice during P. berghei ANKA infection. (A) Parasitaemia, (B) survival and (C) body weight loss of C57BL/6 mice that received 10 mg/kg of A. blazei fraction A or 30 mg/kg of chloroquine three days before infection, then infected with 105 pRBCs, and treated until 7 dpi. Parasitaemia and body weight values are expressed as mean ± SD of 5 mice per group. Log-rank test and *p < 0.05, **p < 0.01 and ***p < 0.001, ANOVA followed Bonferroni’s test